This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Therapeutic Results Obtained in 63 Patients Between 1961 and 1975

Walter F. Lever, MD; Gundula Schaumburg-Lever, MD

Arch Dermatol. 1977;113(9):1236-1241.

Abstract
• Evaluation of the treatment in 63 patients with pemphigus vulgaris showed that six patients (9.5%) died of the consequences of high-dosage prednisone treatment, while 24 patients (38.1%) were free of lesions and not receiving treatment. Immunosuppressants (methotrexate, cyclophosphamide, and azathioprine) are of value in patients with severe pemphigus vulgaris since they often reduce the maintenance dose of prednisone required after high-dosage prednisone treatment. Immunosuppressants are of even greater value in patients in the early, stable stage of pemphigus vulgaris. Of 16 such patients initially treated with a combination of an immunosuppressant and maintenance doses of prednisone not exceeding 40 mg on alternate days, 13 at no time required treatment with higher doses of prednisone. The good results obtained with this method emphasize the importance of diagnosing and treating pemphigus vulgaris in its early stage.

(Arch Dermatol 113:1236-1241, 1977)

Author Affiliations
From the Department of Dermatology, Tufts University School of Medicine and New England Medical Center, Boston.

Footnotes
Accepted for publication Feb 16, 1977.

Reprint requests to 280 Washington St, Brighton, MA 02135 (Dr Lever).

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Comparison of Oral Methylprednisolone Plus Azathioprine or Mycophenolate Mofetil for the Treatment of Pemphigus.
Beissert et al.
Arch Dermatol 2006;142:1447-1454.
ABSTRACT | FULL TEXT  

Pemphigus Vulgaris IgG and Methylprednisolone Exhibit Reciprocal Effects on Keratinocytes
Nguyen et al.
J. Biol. Chem. 2004;279:2135-2146.
ABSTRACT | FULL TEXT  

Consensus Statement on the Use of Intravenous Immunoglobulin Therapy in the Treatment of Autoimmune Mucocutaneous Blistering Diseases
Ahmed and Dahl
Arch Dermatol 2003;139:1051-1059.
ABSTRACT | FULL TEXT  

PEMPHIGUS VULGARIS: UPDATE ON ETIOPATHOGENESIS, ORAL MANIFESTATIONS, AND MANAGEMENT
Scully and Challacombe
CROBM 2002;13:397-408.
ABSTRACT | FULL TEXT  

Methotrexate as an Adjuvant Treatment for Pemphigus Vulgaris
Smith and Bystryn
Arch Dermatol 1999;135:1275-1276.
FULL TEXT  

Treatment of Pemphigus Vulgaris With Brief, High-Dose Intravenous Glucocorticoids
Werth
Arch Dermatol 1996;132:1435-1439.
ABSTRACT  

The Adjuvant Therapy of Pemphigus: An Update
Bystryn and Steinman
Arch Dermatol 1996;132:203-212.
ABSTRACT  

Management of Acquired Bullous Skin Diseases
Fine
NEJM 1995;333:1475-1484.
FULL TEXT  

Treatment of Pemphigus Vulgaris With Pulse Intravenous Cyclophosphamide
Pandya and Sontheimer
Arch Dermatol 1992;128:1626-1630.
ABSTRACT  

The Use and Abuse of Immunosuppressive Agents in Dermatology
Bell and Weinstein
Arch Dermatol 1985;121:195-196.
ABSTRACT  

Adjuvant Therapy of Pemphigus
Bystryn
Arch Dermatol 1984;120:941-951.
ABSTRACT  

Treatment of Pemphigus Vulgaris: Results Obtained in 84 Patients Between 1961 and 1982
Lever and Schaumburg-Lever
Arch Dermatol 1984;120:44-47.
ABSTRACT  

Vesiculobullous Skin Diseases With Prominent Immunologic Feature
Zweiman and Millikan
JAMA 1982;248:2623-2626.
ABSTRACT  

Pemphigus Vulgaris: Superior Sensitivity of Monkey Esophagus in the Determination of Pemphigus Antibody
Feibelman et al.
Arch Dermatol 1981;117:561-562.
ABSTRACT  

Pemphigus: Current Concepts
AHMED et al.
ANN INTERN MED 1980;92:396-405.
ABSTRACT  

Dermatology: An Annotated Bibliography of Recent Literature: References to Journal Articles and Other Papers
DERMATOLOGY COMMITTEE
ANN INTERN MED 1979;91:804-805.
ABSTRACT  

Correlation of Antibodies in Skin and Serum With Disease Severity in Pemphigus
Judd and Lever
Arch Dermatol 1979;115:428-432.
ABSTRACT  

Fate of Pemphigus Antibody Following Successful Therapy: Preliminary Evaluation of Pemphigus Antibody Determinations to Regulate Therapy
O'Loughlin et al.
Arch Dermatol 1978;114:1769-1772.
ABSTRACT  

Successful Use of Cyclophosphamide and Prednisone for Initial Treatment of Pemphigus Vulgaris
Fellner et al.
Arch Dermatol 1978;114:889-894.
ABSTRACT